Update: Category 3 on-site clinical research visits can resume January 24

January 21, 2022

Dear Clinical Research Community,

We are writing to announce an early termination of the hold on Category 3 on-site clinical research visits effective Monday, January 24. All Category 3 research activities can resume at that time, with careful attention to continued compliance with UCSF’s COVID policies. This decision is based on the metrics we have been following: UCSF/ZSFG COVID hospitalizations; UCSF employee COVID cases; UCSF Health/ZSFG clinical workforce strength; and San Francisco (SF) County COVID cases. We believe the available data and modeling demonstrate with confidence that we are at or near the peak in COVID hospitalizations and employee cases, secure in our critical clinical workforce numbers, and past the peak in local SF County COVID cases.

We appreciate the partnership and patience you all have shown these last three weeks during the hold, reducing your research activities to protect the health of our participants and preserve our clinical workforce. The Office of Research will continue to follow the pandemic closely and further adjust UCSF policies as conditions dictate, recognizing and respecting the impact these restrictions have on the research community.

Please let us know at [email protected] if you have any questions or concerns.

Best wishes,

Daniel H. Lowenstein, MD
Executive Vice Chancellor and Provost
Dr. Robert B. and Mrs. Ellinor Aird Professor of Neurology

Harold R. Collard, MD, MS
University of California San Francisco